| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.015 | 0.6 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.041 | 0.6 |